Frontlight ResearchEarly access
Trial site
Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy
- 7running trials
- 15closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Lung cancer21 trials
- Bladder cancer1 trial
- Bronchiectasis1 trial
- Cystic fibrosis1 trial
- Liver and biliary tract cancer1 trial
- Phase
- Phase 314 trials
- Phase 24 trials
- Phase 11 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed14 trials
- Recruiting4 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Hoffmann-La Roche6 trials
- Maia Biotechnology2 trials
- Mirati Therapeutics Inc.2 trials
- AstraZeneca1 trial
- BeiGene1 trial
- and 10 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Bronchiectasis1 recruiting
- Cystic fibrosis1 recruiting
Closed trials
Completed
A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC
Recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026